- 2
- 0
- 约1.67万字
- 约 48页
- 2018-12-01 发布于浙江
- 举报
GOLD解读与雾化吸入激素在AECOPD中应用.ppt
雾化糖皮质激素治疗非酸中毒AECOPD, 替代或减少全身激素的剂量;并减轻全身激素的副作用; * PERMISSION TO ADAPT TABLE TO BE REQUESTED UPON APPROVAL A total of 121 patients completed the study (BD only, n=39; BD + PRED, n=40; BD + BUD, n=42).Gunen et al 2007/4/4 The percentages of patients with relatively early and delayed discharge were not significantly different among the groups.Gunen et al 2007/6/4 Percentages of patients discharged at day 10 were 54%, 50%, and 45% for the BD only, BD + PRED, and BD + BUD groups, respectively.Gunen et al 2007/6/4 Discharge was delayed (15 days) in 10%, 10%, and 7% in the BD only, BD + PRED, and BD + BUD groups, respectively.Gunen et al 2007/6/4 There was a trend toward a significant difference in favor of the corticosteroid groups for exacerbations and re-hospitalization 1 month after discharge, but there were no significant differences across treatments.Gunen et al 2007/7/1 Within 1 month of discharge, there were 14, 8, and 9 exacerbations in the BD only, BD + PRED, and BD + BUD groups, respectively.Gunen et al 2007/6/5 These exacerbations resulted in 8, 4, and 5 hospitalizations in the BD only, BD + PRED, and BD + BUD groups, respectively, during the month after discharge.Gunen et al 2007/7/1 Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J. 2007. Insert full citation when in print With regard to the absolute values of arterial blood gases and spirometric measurements at 10 days, mean forced expiratory flow between 25 and 75% of FVC (FEF25–75%) value in group 3 was significantly higher than the values in group 1 and 2 (p50.03 and p50.027 respectively). In addition to this, while direct comparison of arterial blood gases and spirometric parameters did not reveal any difference between group 1 and 2, FEV1 was also found to be significantly higher in group 3 than in group 1 (p=0.004). 糖皮质激素抗炎作用有基因和非基因两个途径。基因途径主要是通过细胞质受体所介导,包括与DNA直接结合(A)或转录因子失活(B)导 致使转录发生改变。相反,非基因途径主要包括与
您可能关注的文档
- ERCP诊治指南(2010年版)解读.ppt
- ESC2015年 指南-室性心律失常和心脏猝死.docx
- ESC2017年 ESC最新STEMI指南(中文版).ppt
- ESC心血管病预防指南要点.ppt
- ESI 中心理学与相关领域热点分析.pdf
- ESPGHAN2014年儿童胃肠炎指南中文简译版.pdf
- GOLD 解读2016年急诊科.pptx
- H7 N9诊疗(2017年指南解读).ppt
- H7 N9防控中消毒隔离和防护2016年.ppt
- HAPVAP治疗取胜之道2015年.pdf
- 慢性阻塞性肺疾病2014.ppt
- 找准必然因素-应对偶发事件、张秀.ppt
- 授导型教学设计(三).ppt
- 接受高致吐性化疗患者的止吐治疗策略2016.ppt
- 教师心理健康状况与职业倦怠干预——基于2024年全国教师心理健康筛查与干预项目数据.docx
- 教育经费使用绩效评价与优化路径研究——基于2024年全国教育经费使用绩效评价与改进数据.docx
- 策略定期报告:历史的“春节后”.docx
- 固态电池行业深度系列四:固态技术突破装车在即,太空领域打开想象空间.pdf
- 从海外金属包装发展复盘看行业价值重构机遇,整合创造双寡头格局,优质结构提升利润率.pdf
- 商业航天%26太空光伏行业系列深度:商业航天规模化在即,太空光伏打开成长空间.pdf
原创力文档

文档评论(0)